Lokavant is an IT firm that offers real-time visualizations, risk alerts, artificial intelligence, and human insight services.
Lokavant is an IT firm that offers real-time visualizations, risk alerts, artificial intelligence, and human insight services.
Stage: Series A (includes Series A extension)
Total funding: 29000000.00
Flagship product: Spectrum (AI-powered study forecasting)
Founded: 2020
Employees (approx.): 19
Origin: Incubated within Roivant Sciences; spun out in 2023
Clinical trial planning and execution (enrollment forecasting, operational risk detection, study oversight).
2020
Clinical trial intelligence / Life sciences analytics
21000000.00
Roivant Sciences participated; Edison GP Gregg Michaelson joined Lokavant's board.
8000000.00
Described as a strategic investment to expand Lokavant's AI and predictive platform into Asia-Pacific, including plans for an APAC headquarters in Tokyo.
“Led by growth investor Edison Partners with participation from Roivant Sciences; Mitsui & Co. joined as a strategic investor to support APAC expansion.”